Genetic mutations associated with lung cancer metastasis to the brain

Hashim M Aljohani; Mohamed Aittaleb; John M Furgason; Peter Amaya; Ayham Deeb; Jeffery J Chalmers; El Mustapha Bahassi

doi:10.1093/mutage/gey003

journal article Feb 21, 2018

Genetic mutations associated with lung cancer metastasis to the brain

Hashim M Aljohani Mohamed Aittaleb John M Furgason Peter Amaya Ayham Deeb Jeffery J Chalmers El Mustapha Bahassi

Mutagenesis Vol. 33 No. 2 pp. 137-145 · Oxford University Press (OUP)

View at Publisher Save 10.1093/mutage/gey003

Topics

No keywords indexed for this article. Browse by subject →

References

66

[1]

Chaffer "A perspective on cancer cell metastasis" Science (2011)

[2]

Eichler "The biology of brain metastases-translation to new therapies" Nat. Rev. Clin. Oncol (2011)

[3]

Popper "Progression and metastasis of lung cancer" Cancer Metastasis Rev (2016)

[4]

Kim "Tumor self-seeding by circulating cancer cells" Cell (2009)

[5]

Nguyen "Metastasis: from dissemination to organ-specific colonization" Nat. Rev. Cancer (2009)

[6]

Pantel "Cancer micrometastases" Nat. Rev. Clin. Oncol (2009)

[7]

Jemal "Global cancer statistics" CA Cancer J. Clin (2011)

[8]

Yu "Circulating tumor cells: approaches to isolation and characterization" J. Cell Biol (2011)

[9]

Krebs "Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer" J. Clin. Oncol (2011)

[10]

Cohen "Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer" Ann. Oncol (2009)

[11]

de Bono "Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer" Clin. Cancer Res (2008)

[12]

Cristofanilli "Circulating tumor cells, disease progression, and survival in metastatic breast cancer" N. Engl. J. Med (2004)

[13]

Budd "Circulating tumor cells versus imaging–predicting overall survival in metastatic breast cancer" Clin. Cancer Res (2006)

[14]

Zhang "Mechanistic studies of the Nrf2-Keap1 signaling pathway" Drug Metab. Rev (2006)

[15]

Homma "Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer" Clin. Cancer Res (2009)

[16]

Singh "Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer" PLoS Med (2006)

[17]

Padmanabhan "Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer" Mol. Cell (2006)

[18]

Kensler "Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway" Annu. Rev. Pharmacol. Toxicol (2007)

[19]

Itoh "Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain" Genes Dev (1999)

[20]

Cullinan "The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase" Mol. Cell. Biol (2004)

[21]

Furukawa "BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase" Mol. Cell Biol (2005)

[22]

Kobayashi "Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2" Mol. Cell Biol (2004)

[23]

Zhang "Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex" Mol. Cell Biol (2004)

[24]

Tong "Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response" Mol. Cell Biol (2007)

[25]

Zhang "Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway" J. Biol. Chem (2005)

[26]

Itoh "An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements" Biochem. Biophys. Res. Commun (1997)

[27]

Katoh "Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription" Genes Cells (2001)

[28]

Katsuoka "Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes" Mol. Cell Biol (2005)

[29]

Nioi "Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence" Biochem. J (2003)

[30]

Shen "Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein" J. Biol. Chem (2004)

[31]

Zhu "Functional characterization of transcription regulators that interact with the electrophile response element" Biochem. Biophys. Res. Commun (2001)

[32]

Taguchi "Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution" Genes Cells (2011)

[33]

Sporn "NRF2 and cancer: the good, the bad and the importance of context" Nat. Rev. Cancer (2012)

[34]

DeNicola "Oncogene-induced Nrf2 transcription promotes ROS detoxiﬁcation and tumorigenesis" Nature (2011)

[35]

Hanada "Methylation of the KEAP1 gene promoter region in human colorectal cancer" BMC Cancer (2012)

[36]

Zhang "Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth" Mol. Cancer Ther (2010)

[37]

Adam "Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling" Cancer Cell (2011)

[38]

Ooi "An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma" Cancer Cell (2011)

[39]

Kansanen "The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer" Redox Biol (2013)

[40]

Ma "Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2" Pharmacol. Rev (2012)

[41]

Mitsuishi "Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming" Cancer Cell (2012)

[42]

Chrivia "Phosphorylated CREB binds specifically to the nuclear protein CBP" Nature (1993)

[43]

Eckner "Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor" Genes Dev (1994)

[44]

Ogryzko "The transcriptional coactivators p300 and CBP are histone acetyltransferases" Cell (1996)

[45]

Roth "Histone acetyltransferases" Annu. Rev. Biochem (2001)

[46]

Glozak "Acetylation and deacetylation of non-histone proteins" Gene (2005)

[47]

Yang "Lysine acetylation: codified crosstalk with other posttranslational modifications" Mol. Cell (2008)

[48]

Sun "Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response" Mol. Cell Biol (2009)

[49]

Tang "Acetylation is indispensable for p53 activation" Cell (2008)

[50]

Lara "Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation" Exp. Hematol (2004)

Showing 50 of 66 references

Cited By

40

Liquid biopsies for the monitoring of gliomas and brain metastases in adults

Govert Dwarshuis, Lente L. Kroon · 2025

Acta Neuropathologica

Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers

E. M. Brozos-Vázquez, C. Rodríguez-López · 2023

Frontiers in Immunology

Kelch-like proteins: Physiological functions and relationships with diseases

Xiaoxian Shi, Senfeng Xiang · 2019

Pharmacological Research

Metrics

40

Citations

66

References

Details

Published: Feb 21, 2018
Vol/Issue: 33(2)
Pages: 137-145
License: View

Authors

H

Hashim M Aljohani

Department of Internal Medicine, Division of Hematology and Oncology and UC Brain Tumor Center, Cincinnati, OH, USA; Department of Molecular Genetics and Biochemistry, Cincinnati, OH, USA

M

Mohamed Aittaleb

Department of Internal Medicine, Division of Hematology and Oncology and UC Brain Tumor Center, Cincinnati, OH, USA

J

John M Furgason

Department of Internal Medicine, Division of Hematology and Oncology and UC Brain Tumor Center, Cincinnati, OH, USA; Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA

P

Peter Amaya

William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Koffolt Lab, CBEC, Columbus, OH, USA

A

Ayham Deeb

Department of Internal Medicine, Division of Hematology and Oncology and UC Brain Tumor Center, Cincinnati, OH, USA

J

Jeffery J Chalmers

William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Koffolt Lab, CBEC, Columbus, OH, USA

E

El Mustapha Bahassi

Department of Internal Medicine, Division of Hematology and Oncology and UC Brain Tumor Center, Cincinnati, OH, USA

Funding

University of Cincinnati Award: D100271-F100607

national center for advancing translational sciences of the national institutes of health Award: 1UL1TR001425-01

Gromada Foundation Award: G401471-62624129981

UC Brain Tumor Center Award: F101559-2015

Cite This Article

Hashim M Aljohani, Mohamed Aittaleb, John M Furgason, et al. (2018). Genetic mutations associated with lung cancer metastasis to the brain. Mutagenesis, 33(2), 137-145. https://doi.org/10.1093/mutage/gey003

Genetic mutations associated with lung cancer metastasis to the brain

You May Also Like